Improved Heart Fibrosis, Functional Gains Linked in HFpEF Trial

But regression of myocardial fibrosis wasn't tied to the small LVEF improvement observed in the PIROUETTE trial of pirfenidone in patients with heart failure with preserved ejection fraction.

Related Keywords

United Kingdom , ,Amicus Therapeutics ,York Heart Association ,National Institute For Health Research United Kingdom ,Boehringer Ingelheim ,Univar Solutions ,Novartis ,Lilly Alliance ,Guerbet Laboratories ,Astrazeneca ,Roche Products ,Puretech Health ,Heart Failure ,Preserved Left Ventricular Ejection Fraction ,New York Heart Association ,National Institute ,Health Research ,Roche Products Limited ,Guerbet Laboratories Limited ,Endomyocardial Fibrosis ,Left Ventricular Dysfunction ,